Jinyu Bio-Technology Co Documenti
Documenti
0
Ticker
600201.SS
ISIN
CNE000000Y37
Jinyu Bio-Technology Co SEC Filings
Tipo | Rapporto | Data |
|---|---|---|
| Nessun documento disponibile | ||
Jinyu Bio-Technology Co Documenti 2026
Questa pagina contiene tutti i documenti ufficiali e i filing SEC dell'azione Jinyu Bio-Technology Co (600201.SS, ISIN: CNE000000Y37). Sono incluse le relazioni annuali (Form 10-K), le relazioni trimestrali (Form 10-Q) e le transazioni degli insider (Form 4). Attualmente sono disponibili 0 documenti. I dati vengono aggiornati regolarmente per offrire agli investitori una panoramica completa dei depositi regolamentari di Jinyu Bio-Technology Co.
Jinyu Bio-Technology Co Analisi delle Azioni
Jinyu Bio-Technology Co Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas.